Community/Retail

Shared decision-making can be better incorporated into cardiovascular care guidelines by including decision aids, such as informational flyers or online tools to help patients.

Moderna has advanced 6 programs into late-stage development, including for respiratory conditions, latent and other viruses, oncology, and rare diseases.

Insulin glargine-yfgn is more affordable than the reference product and patients do not require prescriber authorization switch.

Infections were associated with a 1.49-fold increase in the rate of dementia in both the short- and long-term rates, however, the increases were greater in the short term.

Supplemental biologics license application is based on positive results from the phase 3 XTEND-Kids study, demonstrating highly effective bleed protection with once weekly dosing of Altuviiio for children with severe hemophilia A.

In addition to identifying strategies to reduce the adverse effects of sleep and circadian disruption, the study authors identify the impact of obesity on sleep.

Research shows a peak of highly cited COVID-19 studies at the end of 2021 and a significant downward trend by the end of 2022.

Strategies include improving compliance, convenience, symptom management, and reducing stigma around pre-exposure prophylaxis for HIV.

Combining strong evidence-based recommendations with caring, compassionate, and frequent counseling opportunities hopefully will increase vaccine acceptance and ultimately reduce the incidence of HPV and associated cancers among our patients.

Pharmacist successfully mounts challenge to that limitation.

Experts answer questions on influenza vaccines.

In this episode of Pharmacy Focus: Student Edition, we dive deep into the world of scholarship funds from Good Neighbor Pharmacy and Cencora, designed to support Black student pharmacists.

Study results could lead to an FDA approval for MDMA to treat post-traumatic stress disorder by the end of 2023.

Community pharmacies and organizations can collaborate to tailor strategies and interventions and address the challenges and specific needs of the community.

With some of the most effective antidepressants containing a black box warning, safe and effective treatment for young adults is hard to come by.

Products include Cyanocobalamin Nasal Spray, Chlorpromazine Hydrochloride Tablets USP, Tiotropium Bromide Inhalation Powder, 18 mcg/ capsule, and Sevelamer Hydrochloride Tablets USP.

As a once-daily oral treatment, orforglipron could help address barriers to injectable medications, such as semaglutide and liraglutide.

Expert panelists addressed concerns about the COVID-19 vaccine costs, availability, efficacy, and timing.

Products include Nirsevimab-alip, Remdesivir, Inclisiran, and Lecanemab-irmb.

By educating their patients on the provisions of the Inflation Reduction Act, pharmacists can have an even greater impact by increasing vaccine uptake in historically underserved groups.

Heart disease prevention efforts should acknowledge non-biological factors that can cause issues within cardiovascular health rather than relying on decreasing socioeconomic disparities.

Clinicians raise concerns about immunogenicity, product quality, and reimbursement for biosimilars.

Compared with COVID-19 vaccination alone, recent study findings show health care workers who received both a COVID-19 booster and influenza vaccinations did not have lower immune response or more frequent adverse events.

The act would have permitted health care facilities to stock up on compounded medications without forcing the supplying 503A pharmacies to register as outsourcing facilities.

The use of gefapixant reduces cough frequency but increases adverse events in individuals suffering from a chronic cough.

Symptoms of dementia can be difficult to differentiate from typical age-related behavior changes and other common and potentially curable conditions.

Evidence-based programs and policies to improve vaccine uptake are necessary for both caregivers and the general public because influenza vaccine coverage remains low for both groups.

The CDC emphasized the need for protein-based vaccine options in endorsing a vote by the Advisory Committee on Immunization Practices for the universal recommendation of the 2023-2024 monovalent, XBB containing COVID-19 vaccines.

Children born at 24- through 34-weeks’ gestation could have neurobehavioral problems and developmental dysfunctions, including language, executive function, attention, and behavioral disorders.